March 22, 2017—The Government Accountability Office is investigating whether drug manufacturers are abusing the Orphan Drug Act for profit.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)
Follow | Share | Like